1-6 of 6
Jessica Koach
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface

Jessica Koach, Jessica K. Holien, Hassina Massudi, Daniel R. Carter, Olivia C. Ciampa, Mika Herath, Taylor Lim, Janith A. Seneviratne, Giorgio Milazzo, Jayne E. Murray, Joshua A. McCarroll, Bing Liu, Chelsea Mayoh, Bryce Keenan, Brendan W. Stevenson, Michael A. Gorman, Jessica L. Bell, Larissa Doughty, Stefan Hüttelmaier, Andre Oberthuer, Matthias Fischer, Andrew J. Gifford, Tao Liu, Xiaoling Zhang, Shizhen Zhu, W. Clay Gustafson, Michelle Haber, Murray D. Norris, Jamie I. Fletcher, Giovanni Perini, Michael W. Parker, Belamy B. Cheung, Glenn M. Marshall
Journal: Cancer Research
Series: Author Choice
Cancer Res (2019) 79 (21): 5652–5667.
https://doi.org/10.1158/0008-5472.CAN-19-1112
Published: 01 November 2019
View articletitled, Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface
Open the PDF for Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface in another window
Includes: Supplementary data
Journal Articles

Abstract 3659: Alyref is a novel binding partner and co-factor for MYCN-driven oncogenesis in neuroblastoma

Zsuzsanna Nagy, Maxwell Kanikevich, Jessica Koach, Chelsea Mayoh, Daniel Carter, Tao Liu, Yanhua Du, Cizhong Jiang, Michelle Haber, Murray Norris, Belamy Cheung, Glenn Marshall
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3659.
https://doi.org/10.1158/1538-7445.AM2019-3659
Published: 01 July 2019
View articletitled, Abstract 3659: Alyref is a novel binding partner and co-factor for MYCN-driven oncogenesis in neuroblastoma
Journal Articles

Abstract 2450: MYCN and TFAP4 promote neuroblastoma malignancy by cooperating in the regulation a subset of target genes involved in cancer cell growth and metastasis

Chengyuan Xue, Denise M. Yu, Samuele Gherardi, Jessica Koach, Giorgio Milazzo, Laura Gamble, Bing Liu, Amanda Russell, Tao Liu, Belamy B. Cheung, Glenn M. Marshall, Giovanni Perini, Michelle Haber, Murray D. Norris
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 2450.
https://doi.org/10.1158/1538-7445.AM2016-2450
Published: 15 July 2016
View articletitled, Abstract 2450: MYCN and TFAP4 promote neuroblastoma malignancy by cooperating in the regulation a subset of target genes involved in cancer cell growth and metastasis
Journal Articles

Abstract 962: PA2G4 predicts poor prognosis in neuroblastoma patients and promotes neuroblastoma progression by enhancing MYCN protein stability

Jessica Koach, Bing Liu, Jessica L. Bell, Stefan Hüttelmaier, Tao Liu, Daniel R. Carter, Michelle Haber, Murray D. Norris, Jamie Fletcher, Belamy B. Cheung, Glenn M. Marshall
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 962.
https://doi.org/10.1158/1538-7445.AM2015-962
Published: 01 August 2015
View articletitled, Abstract 962: PA2G4 predicts poor prognosis in neuroblastoma patients and promotes neuroblastoma progression by enhancing MYCN protein stability
Journal Articles

Abstract 3876: TRIM16 is a prognostic marker for patients with lymph node metastatic melanoma.

Belamy B. Cheung, Selina K. Sutton, Owen Tan, Jessica Koach, Bing Liu, Tao Liu, Richard A. Scolyer, Xu Dong Zhang, Glenn M. Marshall
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 3876.
https://doi.org/10.1158/1538-7445.AM2013-3876
Published: 15 April 2013
View articletitled, Abstract 3876: TRIM16 is a prognostic marker for patients with lymph node metastatic melanoma.
Journal Articles

The molecular mechanism of the estrogen-responsive B box protein (EBBP)-mediated anticancer signal

Belamy Cheung, Jessica Bell, Carla D'Andreti, Jessica Koach, Anna Raif, Eric Sekyere, Wayne Thomas, Maria Kavallaris, Murray Norris, Michelle Haber, Glenn Marshall
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 108.
Published: 01 May 2008
View articletitled, The molecular mechanism of the estrogen-responsive B box protein (EBBP)-mediated anticancer signal